As a result, OCT has become the gold standard for the diagnosis of diseases such as AMD, glaucoma, and diabetic macular edema (DME) as well as the primary modality in the management of patients undergoing treatment with anti-vascular endothelial growth factor (anti-VEGF) drugs4,5. This evidence concerns the gene VEGFA and age-related macular degeneration.